BlackRock Investment Management’s Argos Therapeutics, Inc. ARGS Stock Holding History

BlackRock Investment Management’s Portfolio ARGS Stock Details ARGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$328K	Buy	3,343 +19	+0.6%	+$1.78K	﹤0.01%	3147
2016 Q3	$330K	Buy	3,324 +1,346	+68%	+$141K	﹤0.01%	3165
2016 Q2	$243K	Buy	1,978 +1,891	+2,174%	+$252K	﹤0.01%	3261
2016 Q1	$11K	Hold	87	–	–	﹤0.01%	3597
2015 Q4	$4K	Buy	87 +8	+10%	+$677	﹤0.01%	3937
2015 Q3	$8K	Hold	79	–	–	﹤0.01%	3808
2015 Q2	$11K	Buy	79 +41	+108%	+$6.55K	﹤0.01%	3708
2015 Q1	$7K	Hold	38	–	–	﹤0.01%	3800
2014 Q4	$8K	Hold	38	–	–	﹤0.01%	3784
2014 Q3	$8K	Hold	38	–	–	﹤0.01%	3782
2014 Q2	$6K	Sell	38 -434	-92%	-$71.8K	﹤0.01%	3855
2014 Q1	$94K	Buy	+472	New	+$94.4K	﹤0.01%	3302

Other funds holding ARGS

Pharmstandard International Luxembourg $29M AUM 3.25% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

SMH

Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AGA

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BlackRock Investment Management's ARGS Position: Q4 2016 in Review

BlackRock Investment Management increased its Argos Therapeutics, Inc. (ARGS) stake by 0.57% in Q4 2016, buying an estimated $1.78K and bringing the position to 3,343 shares worth $328K. The position accounts for ﹤0.01% of the portfolio, ranked #3147.

BlackRock Investment Management first reported a position in ARGS in Q1 2014 and has held it in 12 quarters since. The position peaked at $330K in Q3 2016. 52 funds tracked by Wall St. Rank hold ARGS as of Q4 2016.

BlackRock Investment Management held 3,343 shares of Argos Therapeutics, Inc. worth $328K as of Q4 2016.
BlackRock Investment Management bought 19 Argos Therapeutics, Inc. shares in Q4 2016, an estimated $1.78K.
Argos Therapeutics, Inc. made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3147 holding.
BlackRock Investment Management first reported a position in Argos Therapeutics, Inc. in Q1 2014 and has held it in 12 quarters since.
BlackRock Investment Management's Argos Therapeutics, Inc. position peaked at $330K in Q3 2016.
52 funds tracked by Wall St. Rank held Argos Therapeutics, Inc. as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.